{"entity":{"type":"insider","cik":"0001487645","url":"/insider/0001487645","json_url":"/insider/0001487645.json","name":"Riley Jeffrey Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2013-01-03","last":"2024-04-01","span_basis":"filed_date"},"name_variants":[{"name":"Riley Jeffrey Scott","source":"filing","n_filings":4,"first_seen":"2013-01-03","last_seen":"2024-04-01"}],"transactions":[{"id":3205615,"accession":"0001493152-24-012340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-012340","line_url":"/filing/0001493152-24-012340#line-1","is_derivative":false,"issuer_cik":"0001487645","issuer_name":"Gain Therapeutics, Inc.","issuer_ticker":"GANX","issuer_name_source":null,"issuer_url":"/issuer/0001487645","owner_cik":"0001487645","owner_name":"Riley Jeffrey Scott","owner_display_name":"Riley Jeffrey Scott","owner_url":"/insider/0001487645","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":3.859,"price_display":"3.86","price_state":"stated","total_value":115770.0,"total_display":"115,770.00","total_whole":"115,770","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":4685182,"accession":"0001144204-13-001056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-001056","line_url":"/filing/0001144204-13-001056","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001487645","owner_name":"Riley Jeffrey Scott","owner_display_name":"Riley Jeffrey Scott","owner_url":"/insider/0001487645","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900.0,"shares_display":"2,900","price_per_share":0.17465172413793104,"price_display":"0.17","price_state":"stated","total_value":506.49,"total_display":"506.49","total_whole":"506","shares_owned_after":10400.0,"shares_owned_after_display":"10,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-07","filed_date":"2013-01-07","scope":"insider","n_lines":2},{"id":5253655,"accession":"0001144204-13-000459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-000459","line_url":"/filing/0001144204-13-000459#line-2","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001487645","owner_name":"Riley Jeffrey Scott","owner_display_name":"Riley Jeffrey Scott","owner_url":"/insider/0001487645","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":1.7499,"price_display":"1.75","price_state":"stated","total_value":4899.72,"total_display":"4,899.72","total_whole":"4,900","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-03","scope":"insider"},{"id":4511349,"accession":"0001144204-13-000800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-000800","line_url":"/filing/0001144204-13-000800#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001487645","owner_name":"Riley Jeffrey Scott","owner_display_name":"Riley Jeffrey Scott","owner_url":"/insider/0001487645","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":3420.0,"total_display":"3,420.00","total_whole":"3,420","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-04","scope":"insider"},{"id":5253651,"accession":"0001144204-13-000459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-000459","line_url":"/filing/0001144204-13-000459#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001487645","owner_name":"Riley Jeffrey Scott","owner_display_name":"Riley Jeffrey Scott","owner_url":"/insider/0001487645","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":1.7799,"price_display":"1.78","price_state":"stated","total_value":4805.73,"total_display":"4,805.73","total_whole":"4,806","shares_owned_after":2700.0,"shares_owned_after_display":"2,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-02","filed_date":"2013-01-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819411","name":"Gain Therapeutics, Inc.","url":"/issuer/0001819411","role":"Director","n_filings":1,"first_seen":"2024-04-01","last_seen":"2024-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000894158","name":"Synthetic Biologics, Inc.","url":"/issuer/0000894158","role":"Director, Officer (CEO and President)","n_filings":3,"first_seen":"2013-01-03","last_seen":"2013-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001487645","retrieved_at":"2026-08-22T13:35:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}